As of 9:45 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - myriad genetics inc (MYD)
Nominating Committee* - myriad genetics inc (MYD)
|Name (Connections)||Board Relationships||Title||Key Developments|
|Dennis Langer M.D., J.D.|| 173 Relationships||Director, Chairman of Nominating & Governance Committee and Member of Audit Committee||Myriad Genetics Inc. Announces Executive Changes|
|S. Phanstiel || 62 Relationships||Director, Chairman of Audit Committee and Member of Nominating & Governance Committee||Myriad Genetics Inc. Names Johnathan M. Lancaster as Vice President of Medical Affairs for Oncology, Myriad Genetic Laboratories, Effective February 9, 2015|
*Data is at least as current as the most recent Definitive Proxy.
Sponsored Financial Commentaries